| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |